SynthesisTargeted oncology2013

Comparison of the efficacy and safety of single-agent erlotinib and doublet molecular targeted agents based on erlotinib in advanced non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.

Gaofeng Pan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.